NFATC1 and osteoporosis: wLL suppressed osteoclastogenesis and bone resorption by RANKL in a concentration-dependent manner by modulating the NFATc/c-fos pathway in vitro, and wLL inhibited bone loss in the OVX-induced osteoporosis model in vivo.